{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:30:38Z","timestamp":1792103438527,"version":"4.4.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China and regional science foundation projects","award":["82360394"],"award-info":[{"award-number":["82360394"]}]},{"name":"National Natural Science Foundation of China and regional science foundation projects","award":["82460399"],"award-info":[{"award-number":["82460399"]}]},{"name":"National Natural Science Foundation of China and regional science foundation projects","award":["82360394"],"award-info":[{"award-number":["82360394"]}]},{"name":"Youth Science and Technology Top Talent Program","award":["2022TSYCCX0112"],"award-info":[{"award-number":["2022TSYCCX0112"]}]},{"name":"Youth Science and Technology Top Talent Program","award":["2022TSYCCX0112"],"award-info":[{"award-number":["2022TSYCCX0112"]}]},{"name":"Science and Technology Department of Xinjiang Uygur Autonomous Region, Outstanding Youth Project","award":["2022D01E69"],"award-info":[{"award-number":["2022D01E69"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09509-7","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T06:39:00Z","timestamp":1755758340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Design of a multi-Epitope mRNA vaccine against Brucella type IV secretion system using reverse vaccinology and immunogenicity approaches"],"prefix":"10.1038","volume":"15","author":[{"given":"Jia-Rui","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Xin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Long","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Bing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"9509_CR1","doi-asserted-by":"publisher","unstructured":"Ali, A. et al. Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections. Life Sci. 314, 121332. https:\/\/doi.org\/10.1016\/j.lfs.2022.121332 (Feb. 2023).","DOI":"10.1016\/j.lfs.2022.121332"},{"key":"9509_CR2","doi-asserted-by":"publisher","unstructured":"Laine, C. G., Johnson, V. E., Scott, H. M. & Arenas-Gamboa, A. M. Global Estimate of Human Brucellosis Incidence, Emerg Infect Dis, vol. 29, no. 9, pp. 1789\u20131797, Sep. (2023). https:\/\/doi.org\/10.3201\/eid2909.230052","DOI":"10.3201\/eid2909.230052"},{"key":"9509_CR3","doi-asserted-by":"publisher","unstructured":"Su\u00e1rez-Esquivel, M. et al. Persistence of Brucella abortus lineages revealed by genomic characterization and phylodynamic analysis. PLoS Negl. Trop. Dis. 14 (4), e0008235. https:\/\/doi.org\/10.1371\/journal.pntd.0008235 (Apr. 2020).","DOI":"10.1371\/journal.pntd.0008235"},{"key":"9509_CR4","doi-asserted-by":"publisher","unstructured":"Yang, X. et al. Analysis of the Brucella melitensis epidemic in xinjiang: genotyping, polymorphism, antibiotic resistance and tracing. Ann. Clin. Microbiol. Antimicrob. 23 (1), 71. https:\/\/doi.org\/10.1186\/s12941-024-00724-0 (Aug. 2024).","DOI":"10.1186\/s12941-024-00724-0"},{"key":"9509_CR5","doi-asserted-by":"publisher","unstructured":"Lin, Z. Q. et al. IL-6 and INF-\u03b3 levels in patients with brucellosis in severe epidemic region, xinjiang, China. Infect. Dis. Poverty. 9 (1), 47. https:\/\/doi.org\/10.1186\/s40249-020-00666-7 (May 2020).","DOI":"10.1186\/s40249-020-00666-7"},{"key":"9509_CR6","doi-asserted-by":"publisher","unstructured":"Tian, T. et al. The development of a human Brucella mucosal vaccine: what should be considered? Life Sci. 355, 122986. https:\/\/doi.org\/10.1016\/j.lfs.2024.122986 (Oct. 2024).","DOI":"10.1016\/j.lfs.2024.122986"},{"key":"9509_CR7","doi-asserted-by":"publisher","unstructured":"Jia, B. et al. The clinical features of 590 patients with brucellosis in xinjiang, China with the emphasis on the treatment of complications. PLoS Negl. Trop. Dis. 11 (5), e0005577. https:\/\/doi.org\/10.1371\/journal.pntd.0005577 (May 2017).","DOI":"10.1371\/journal.pntd.0005577"},{"key":"9509_CR8","doi-asserted-by":"publisher","unstructured":"Rezaei Shahrabi, A., Moradkasani, S., Goodarzi, F., Beig, M. & Sholeh, M. Prevalence of Brucella melitensis and Brucella abortus tetracyclines resistance: A systematic review and meta-analysis. Microb. Pathog. 183, 106321. https:\/\/doi.org\/10.1016\/j.micpath.2023.106321 (Oct. 2023).","DOI":"10.1016\/j.micpath.2023.106321"},{"key":"9509_CR9","doi-asserted-by":"publisher","unstructured":"Yang, J. et al. Evasion of host defense by Brucella. Cell. Insight. 3 (1), 100143. https:\/\/doi.org\/10.1016\/j.cellin.2023.100143 (Feb. 2024).","DOI":"10.1016\/j.cellin.2023.100143"},{"key":"9509_CR10","doi-asserted-by":"publisher","unstructured":"Xiong, X. et al. The virb system plays a crucial role in Brucella intracellular infection. Int. J. Mol. Sci. 22, no., https:\/\/doi.org\/10.3390\/ijms222413637 (Jan. 2021). 24, Art. 24.","DOI":"10.3390\/ijms222413637"},{"key":"9509_CR11","doi-asserted-by":"publisher","unstructured":"Amjadi, O., Rafiei, A., Mardani, M., Zafari, P. & Zarifian, A. A review of the Immunopathogenesis of brucellosis. Infect. Dis. 51 (5), 321\u2013333. https:\/\/doi.org\/10.1080\/23744235.2019.1568545 (May 2019).","DOI":"10.1080\/23744235.2019.1568545"},{"key":"9509_CR12","doi-asserted-by":"publisher","unstructured":"Ke, Y., Wang, Y., Li, W. & Chen, Z. Type IV secretion system of Brucella spp. and its effectors, Front. Cell. Infect. Microbiol., vol. 5, Oct. (2015). https:\/\/doi.org\/10.3389\/fcimb.2015.00072","DOI":"10.3389\/fcimb.2015.00072"},{"key":"9509_CR13","doi-asserted-by":"publisher","unstructured":"Zheng, M. et al. Effector proteins of type IV secretion system: weapons of Brucella used to fight against host immunity. Current Stem Cell. Res. & Therapy, 19, 2, pp. 145\u2013153, https:\/\/doi.org\/10.2174\/1574888X18666230222124529","DOI":"10.2174\/1574888X18666230222124529"},{"key":"9509_CR14","doi-asserted-by":"publisher","unstructured":"Yin, Z. et al. Aug., Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS), PLOS ONE, vol. 18, no. 8, p. e0286358, (2023). https:\/\/doi.org\/10.1371\/journal.pone.0286358","DOI":"10.1371\/journal.pone.0286358"},{"key":"9509_CR15","doi-asserted-by":"publisher","unstructured":"Shang, K. et al. Development of a novel multi-epitope vaccine for brucellosis prevention. Heliyon 10 (14), e34721. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34721 (Jul. 2024).","DOI":"10.1016\/j.heliyon.2024.e34721"},{"key":"9509_CR16","doi-asserted-by":"publisher","unstructured":"Shah, M., Rafiq, S. & Woo, H. G. Challenges and considerations in multi-epitope vaccine design surrounding toll-like receptors. Trends Pharmacol. Sci. 45 (12), 1104\u20131118. https:\/\/doi.org\/10.1016\/j.tips.2024.10.013 (Dec. 2024).","DOI":"10.1016\/j.tips.2024.10.013"},{"key":"9509_CR17","doi-asserted-by":"crossref","unstructured":"mRNA-Based. Vaccine Designing against Epstein-Barr Virus to Induce an Immune Response Using Immunoinformatic and Molecular Modelling Approaches. Accessed: Dec. 22, 2024. [Online]. Available: https:\/\/www.mdpi.com\/1660-4601\/19\/20\/13054","DOI":"10.3390\/ijerph192013054"},{"key":"9509_CR18","unstructured":"Frontiers |. mRNA-based platform for preventing and treating Staphylococcus aureus by targeted staphylococcal enterotoxin B. Accessed: Apr. 27, 2025. [Online]. (2024). Available: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.1490044\/full."},{"key":"9509_CR19","doi-asserted-by":"publisher","unstructured":"Bergstrom, C., Fischer, N. O., Kubicek-Sutherland, J. Z. & Stromberg, Z. R. mRNA vaccine platforms to prevent bacterial infections, Trends Mol Med, vol. 30, no. 6, pp. 524\u2013526, Jun. (2024). https:\/\/doi.org\/10.1016\/j.molmed.2024.02.013","DOI":"10.1016\/j.molmed.2024.02.013"},{"key":"9509_CR20","doi-asserted-by":"publisher","unstructured":"The UniProt Consortium. UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res. 51, D523\u2013D531. https:\/\/doi.org\/10.1093\/nar\/gkac1052 (Jan. 2023). no. D1.","DOI":"10.1093\/nar\/gkac1052"},{"key":"9509_CR21","doi-asserted-by":"publisher","unstructured":"Dalsass, M., Brozzi, A., Medini, D. & Rappuoli, R. Comparison of Open-Source reverse vaccinology programs for bacterial vaccine antigen discovery. Front. Immunol. 10, 113. https:\/\/doi.org\/10.3389\/fimmu.2019.00113 (Feb. 2019).","DOI":"10.3389\/fimmu.2019.00113"},{"key":"9509_CR22","doi-asserted-by":"publisher","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8, p. (4). https:\/\/doi.org\/10.1186\/1471-2105-8-4 (Jan. 2007).","DOI":"10.1186\/1471-2105-8-4"},{"key":"9509_CR23","doi-asserted-by":"publisher","unstructured":"S. K et al., Development of a novel multi-epitope vaccine for brucellosis prevention. Heliyon, 10, 14, Jul. (2024). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34721","DOI":"10.1016\/j.heliyon.2024.e34721"},{"key":"9509_CR24","doi-asserted-by":"publisher","unstructured":"Sharma, N. et al. AlgPred 2.0: an improved method for predicting allergenic proteins and mapping of IgE epitopes. Brief. Bioinform. 22 (4), bbaa294. https:\/\/doi.org\/10.1093\/bib\/bbaa294 (Jul. 2021).","DOI":"10.1093\/bib\/bbaa294"},{"key":"9509_CR25","doi-asserted-by":"publisher","unstructured":"Sharma, N., Naorem, L. D., Jain, S. & Raghava, G. P. S. ToxinPred2: an improved method for predicting toxicity of proteins, Briefings in Bioinformatics, vol. 23, no. 5, p. bbac174, Sep. (2022). https:\/\/doi.org\/10.1093\/bib\/bbac174","DOI":"10.1093\/bib\/bbac174"},{"issue":"7","key":"9509_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41587-021-01156-3","volume":"40","author":"F Teufel","year":"2022","unstructured":"Teufel, F. et al. SignalP 6.0 predicts all five types of signal peptides using protein Language models. Nat. Biotechnol. 40 (7), 1023\u20131025. https:\/\/doi.org\/10.1038\/s41587-021-01156-3 (2022).","journal-title":"Nat. Biotechnol."},{"key":"9509_CR27","doi-asserted-by":"publisher","unstructured":"Shi, H. et al. Development of innovative multi-epitope mRNA vaccine against central nervous system tuberculosis using in Silico approaches. PLoS One. 19 (9), e0307877. https:\/\/doi.org\/10.1371\/journal.pone.0307877 (Sep. 2024).","DOI":"10.1371\/journal.pone.0307877"},{"key":"9509_CR28","doi-asserted-by":"publisher","unstructured":"Tan, D. et al. Apr., Construction and efficacy testing of DNA vaccines containing HLA-A*02:01-restricted SARS-CoV-2 T-cell epitopes predicted by immunoinformatics, Acta Biochim Biophys Sin (Shanghai), vol. 56, no. 7, pp. 986\u2013996, (2024). https:\/\/doi.org\/10.3724\/abbs.2024039","DOI":"10.3724\/abbs.2024039"},{"key":"9509_CR29","doi-asserted-by":"publisher","unstructured":"Zhang, F. et al. The immunogenicity of OMP31 peptides and its protection against Brucella melitensis infection in mice. Sci. Rep. 9, 3512. https:\/\/doi.org\/10.1038\/s41598-019-40084-w (Mar. 2019).","DOI":"10.1038\/s41598-019-40084-w"},{"key":"9509_CR30","doi-asserted-by":"publisher","unstructured":"S. J et al., In Silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptD. Scientific Reports, 14, 1, Mar. (2024). https:\/\/doi.org\/10.1038\/s41598-024-57793-6","DOI":"10.1038\/s41598-024-57793-6"},{"key":"9509_CR31","doi-asserted-by":"publisher","unstructured":"Wang, Y. et al. A multi-epitope subunit vaccine based on CU\/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB\/C mice. Int. Immunopharmacol. 127, 111351. https:\/\/doi.org\/10.1016\/j.intimp.2023.111351 (Jan. 2024).","DOI":"10.1016\/j.intimp.2023.111351"},{"key":"9509_CR32","doi-asserted-by":"publisher","unstructured":"Galanis, K. A. et al. Linear B-Cell epitope prediction for in Silico vaccine design: A performance review of methods available via Command-Line interface. Int. J. Mol. Sci. 22 (6), 3210. https:\/\/doi.org\/10.3390\/ijms22063210 (Mar. 2021).","DOI":"10.3390\/ijms22063210"},{"key":"9509_CR33","doi-asserted-by":"publisher","unstructured":"Ponomarenko, J. et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform. 9 (1), 514. https:\/\/doi.org\/10.1186\/1471-2105-9-514 (Dec. 2008).","DOI":"10.1186\/1471-2105-9-514"},{"key":"9509_CR34","doi-asserted-by":"publisher","unstructured":"Yan, Y., Tao, H., He, J. & Huang, S. Y. The HDOCK server for integrated protein-protein Docking. Nat. Protoc. 15 (5), 1829\u20131852. https:\/\/doi.org\/10.1038\/s41596-020-0312-x (May 2020).","DOI":"10.1038\/s41596-020-0312-x"},{"key":"9509_CR35","doi-asserted-by":"publisher","unstructured":"Yan, Y., Zhang, D., Zhou, P., Li, B. & Huang, S. Y. HDOCK: a web server for protein-protein and protein-DNA\/RNA Docking based on a hybrid strategy. Nucleic Acids Res. 45, W365\u2013W373. https:\/\/doi.org\/10.1093\/nar\/gkx407 (Jul. 2017). no. W1.","DOI":"10.1093\/nar\/gkx407"},{"key":"9509_CR36","doi-asserted-by":"publisher","unstructured":"Wei, Y. et al. Advances of computational methods enhance the development of multi-epitope vaccines. Brief. Bioinform. 26 (1), bbaf055. https:\/\/doi.org\/10.1093\/bib\/bbaf055 (Feb. 2025).","DOI":"10.1093\/bib\/bbaf055"},{"key":"9509_CR37","doi-asserted-by":"publisher","unstructured":"Azami, Z., Farahmand, M. & Kavousi, M. A new multi-epitope DNA vaccine against Helicobacter Pylori infection in a BALB\/c mouse model, Heliyon, vol. 10, no. 21, p. e39433, Oct. (2024). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39433","DOI":"10.1016\/j.heliyon.2024.e39433"},{"key":"9509_CR38","doi-asserted-by":"publisher","first-page":"e240201","DOI":"10.1590\/0074-02760240201","volume":"120","author":"AG Felice","year":"2025","unstructured":"Felice, A. G. et al. In Silico construction of a multi-epitope vaccine (RGME-VAC\/ATS-1) against the Rickettsia genus using immunoinformatics. Mem. Inst. Oswaldo Cruz. 120, e240201. https:\/\/doi.org\/10.1590\/0074-02760240201 (2025).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"9509_CR39","doi-asserted-by":"publisher","unstructured":"Ismail, S. & Barakat, K. Designing a multi-neoantigen vaccine for melanoma: integrating immunoinformatics and biophysics methods. Comput. Biol. Med. 190, 110081. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110081 (May 2025).","DOI":"10.1016\/j.compbiomed.2025.110081"},{"key":"9509_CR40","doi-asserted-by":"publisher","unstructured":"Zaib, S. et al. Designing multi-epitope Monkeypox virus-specific vaccine using immunoinformatics approach. J. Infect. Public Health. 16 (1, p. 107, ). https:\/\/doi.org\/10.1016\/j.jiph.2022.11.033 (Dec. 2022).","DOI":"10.1016\/j.jiph.2022.11.033"},{"key":"9509_CR41","doi-asserted-by":"publisher","unstructured":"Jaan, S., Zaman, A., Ahmed, S., Shah, M. & Ojha, S. C. mRNA vaccine designing using Chikungunya virus E glycoprotein through Immunoinformatics-Guided approaches. Vaccines (Basel). 10 (9). https:\/\/doi.org\/10.3390\/vaccines10091476 (Sep. 2022).","DOI":"10.3390\/vaccines10091476"},{"key":"9509_CR42","doi-asserted-by":"publisher","unstructured":"Cn, M., P, B. & R. A, and SOLpro: accurate sequence-based prediction of protein solubility. Bioinf. (Oxford England). 25 (17). https:\/\/doi.org\/10.1093\/bioinformatics\/btp386 (Jan. 2009).","DOI":"10.1093\/bioinformatics\/btp386"},{"key":"9509_CR43","doi-asserted-by":"publisher","unstructured":"Kishore Kumar, G. et al. Polymorphisms of extrinsic death receptor apoptotic genes (FAS \u2013\u2009670 G\u2009>\u2009A, FASL \u2013\u2009844 T\u2009>\u2009C) in coronary artery disease. Apoptosis 21 (5), 558\u2013565. https:\/\/doi.org\/10.1007\/s10495-016-1232-7 (May 2016).","DOI":"10.1007\/s10495-016-1232-7"},{"key":"9509_CR44","doi-asserted-by":"publisher","unstructured":"Y. Z et al., Nano DNA vaccine encoding Toxoplasma gondii histone deacetylase SIR2 enhanced protective immunity in mice. Pharmaceutics, 13, 10, Sep. (2021). https:\/\/doi.org\/10.3390\/pharmaceutics13101582","DOI":"10.3390\/pharmaceutics13101582"},{"key":"9509_CR45","doi-asserted-by":"publisher","unstructured":"Stolfi, P. et al. In-silico evaluation of adenoviral COVID-19 vaccination protocols: assessment of immunological memory up to 6 months after the third dose. Front. Immunol. 13 https:\/\/doi.org\/10.3389\/fimmu.2022.998262 (Oct. 2022).","DOI":"10.3389\/fimmu.2022.998262"},{"key":"9509_CR46","doi-asserted-by":"publisher","unstructured":"Negahdari, B., Sarkoohi, P., Nezhad, F. G., Shahbazi, B. & Ahmadi, K. Design of multi-epitope vaccine candidate based on ompa, CarO and ZnuD proteins against multi-drug resistant Acinetobacter baumannii. Heliyon 10 (14), e34690. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34690 (Jul. 2024).","DOI":"10.1016\/j.heliyon.2024.e34690"},{"key":"9509_CR47","doi-asserted-by":"publisher","unstructured":"G, D. & G. C and SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput. Appl. Biosciences: CABIOS. 11 (6). https:\/\/doi.org\/10.1093\/bioinformatics\/11.6.681 (Dec. 1995).","DOI":"10.1093\/bioinformatics\/11.6.681"},{"key":"9509_CR48","doi-asserted-by":"publisher","unstructured":"Baek, M. et al. Accurate prediction of protein structures and interactions using a 3-track neural network. Science 373 (6557), 871\u2013876. https:\/\/doi.org\/10.1126\/science.abj8754 (Aug. 2021).","DOI":"10.1126\/science.abj8754"},{"key":"9509_CR49","doi-asserted-by":"publisher","unstructured":"Mj, S. W. M and ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins, Nucleic acids research, vol. 35, no. Web Server issue, Jul. (2007). https:\/\/doi.org\/10.1093\/nar\/gkm290","DOI":"10.1093\/nar\/gkm290"},{"key":"9509_CR50","doi-asserted-by":"publisher","unstructured":"Tn, A. Design of a novel multi-epitopes vaccine against Escherichia fergusonii: a pan-proteome based in- Silico approach. Front. Immunol. 14 https:\/\/doi.org\/10.3389\/fimmu.2023.1332378 (Aug. 2023).","DOI":"10.3389\/fimmu.2023.1332378"},{"key":"9509_CR51","doi-asserted-by":"publisher","unstructured":"H. M et al., Vaccinomics strategy for developing a unique multi-epitope monovalent vaccine against Marburg marburgvirus. Infection Genet. Evolution: J. Mol. Epidemiol. Evolutionary Genet. Infect. Diseases, 70, Jun. (2019). https:\/\/doi.org\/10.1016\/j.meegid.2019.03.003","DOI":"10.1016\/j.meegid.2019.03.003"},{"key":"9509_CR52","doi-asserted-by":"publisher","unstructured":"Farzan, M. et al. Immunoinformatics-based multi-epitope vaccine design for the re-emerging Monkeypox virus. Int. Immunopharmacol. 123, 110725. https:\/\/doi.org\/10.1016\/j.intimp.2023.110725 (Oct. 2023).","DOI":"10.1016\/j.intimp.2023.110725"},{"key":"9509_CR53","doi-asserted-by":"publisher","unstructured":"Ponomarenko, J. et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform. 9, 514. https:\/\/doi.org\/10.1186\/1471-2105-9-514 (Dec. 2008).","DOI":"10.1186\/1471-2105-9-514"},{"key":"9509_CR54","doi-asserted-by":"publisher","unstructured":"Jy, L., Y, L., Xx, G., H, C. & G. X, and TLR2 and TLR4 signaling pathways are required for Recombinant Brucella abortus BCSP31-induced cytokine production, functional upregulation of mouse macrophages, and the Th1 immune response in vivo and in vitro. Cell Mol. Immunol. 11 (5). https:\/\/doi.org\/10.1038\/cmi.2014.28 (Sep. 2014).","DOI":"10.1038\/cmi.2014.28"},{"key":"9509_CR55","doi-asserted-by":"publisher","unstructured":"Sorin, E. J. & Pande, V. S. Exploring the helix-coil transition via all-atom equilibrium ensemble simulations, Biophys J, vol. 88, no. 4, pp. 2472\u20132493, Apr. (2005). https:\/\/doi.org\/10.1529\/biophysj.104.051938","DOI":"10.1529\/biophysj.104.051938"},{"key":"9509_CR56","doi-asserted-by":"publisher","unstructured":"Essmann, U. et al. A smooth particle mesh Ewald method, The Journal of Chemical Physics, vol. 103, no. 19, pp. 8577\u20138593, Nov. (1995). https:\/\/doi.org\/10.1063\/1.470117","DOI":"10.1063\/1.470117"},{"key":"9509_CR57","doi-asserted-by":"publisher","unstructured":"Parrinello, M. & Rahman, A. Polymorphic transitions in single crystals: A new molecular dynamics method, Journal of Applied Physics, vol. 52, no. 12, pp. 7182\u20137190, Dec. (1981). https:\/\/doi.org\/10.1063\/1.328693","DOI":"10.1063\/1.328693"},{"issue":"24","key":"9509_CR58","doi-asserted-by":"publisher","first-page":"13876","DOI":"10.1080\/07391102.2023.2279276","volume":"42","author":"N Khan","year":"2024","unstructured":"Khan, N. et al. A novel therapeutic approach to prevent Helicobacter pylori induced gastric cancer using networking biology, molecular docking, and simulation approaches. J. Biomol. Struct. Dyn. 42 (24), 13876\u201313889. https:\/\/doi.org\/10.1080\/07391102.2023.2279276 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"9509_CR59","doi-asserted-by":"publisher","unstructured":"M. M et al., Proteome-Wide screening of potential vaccine targets against Brucella melitensis. Vaccines, 11, 2, Jan. (2023). https:\/\/doi.org\/10.3390\/vaccines11020263","DOI":"10.3390\/vaccines11020263"},{"key":"9509_CR60","doi-asserted-by":"publisher","unstructured":"Jiao, H. et al. The mechanism of facultative intracellular parasitism of Brucella. Int. J. Mol. Sci. 22 (7), 3673. https:\/\/doi.org\/10.3390\/ijms22073673 (Apr. 2021).","DOI":"10.3390\/ijms22073673"},{"key":"9509_CR61","doi-asserted-by":"publisher","unstructured":"Ghanbari, M. K. et al. One health approach to tackle brucellosis: a systematic review. Trop. Med. Health. 48 (1), 86. https:\/\/doi.org\/10.1186\/s41182-020-00272-1 (Oct. 2020).","DOI":"10.1186\/s41182-020-00272-1"},{"key":"9509_CR62","unstructured":"mRNA, V. & Era\u2014Mechanisms Drug Platform and Clinical Prospection. Accessed: Dec. 24, 2024. [Online]. Available: https:\/\/www.mdpi.com\/1422-0067\/21\/18\/6582#B23-ijms-21-06582"},{"key":"9509_CR63","doi-asserted-by":"publisher","unstructured":"Sahin, U., Karik\u00f3, K. & T\u00fcreci, \u00d6. mRNA-based therapeutics\u2013developing a new class of drugs, Nat Rev Drug Discov, vol. 13, no. 10, pp. 759\u2013780, Oct. (2014). https:\/\/doi.org\/10.1038\/nrd4278","DOI":"10.1038\/nrd4278"},{"key":"9509_CR64","doi-asserted-by":"publisher","unstructured":"Gallie, D. R. The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency. Genes Dev. 5 (11), 2108\u20132116. https:\/\/doi.org\/10.1101\/gad.5.11.2108 (Nov. 1991).","DOI":"10.1101\/gad.5.11.2108"},{"key":"9509_CR65","doi-asserted-by":"publisher","unstructured":"Jaan, S., Zaman, A., Ahmed, S., Shah, M. & Ojha, S. C. mRNA vaccine designing using Chikungunya virus E glycoprotein through Immunoinformatics-Guided approaches. Vaccines (Basel). 10 (9), 1476. https:\/\/doi.org\/10.3390\/vaccines10091476 (Sep. 2022).","DOI":"10.3390\/vaccines10091476"},{"key":"9509_CR66","doi-asserted-by":"publisher","unstructured":"Isaac, I. et al. Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery, ACS Nano, vol. 18, no. 42, pp. 29045\u201329058, Oct. (2024). https:\/\/doi.org\/10.1021\/acsnano.4c10154","DOI":"10.1021\/acsnano.4c10154"},{"key":"9509_CR67","doi-asserted-by":"publisher","unstructured":"Zeng, J. Y. et al. Cholesterol-Derived mannosylated Polypeptide-Formed lipid nanoparticles for efficient in vivo mRNA delivery. Small Methods. 2401712, e. https:\/\/doi.org\/10.1002\/smtd.202401712 (Apr. 2025).","DOI":"10.1002\/smtd.202401712"},{"key":"9509_CR68","doi-asserted-by":"publisher","unstructured":"Zhao, D. & Huang, Z. Effect of His-Tag on Expression, Purification, and Structure of Zinc Finger Protein, ZNF191(243\u2013368), Bioinorg Chem Appl, vol. p. 8206854, 2016, (2016). https:\/\/doi.org\/10.1155\/2016\/8206854","DOI":"10.1155\/2016\/8206854"},{"key":"9509_CR69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fcimb.2015.00072","volume":"5","author":"Y Ke","year":"2015","unstructured":"Ke, Y., Wang, Y., Li, W. & Chen, Z. Type IV secretion system of Brucella spp. And its effectors. Front. Cell. Infect. Microbiol. 5, 72. https:\/\/doi.org\/10.3389\/fcimb.2015.00072 (2015).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"9509_CR70","doi-asserted-by":"publisher","unstructured":"Liu, J. et al. Ionizable lipids with branched linkers enhance the delivery of mRNA vaccines. ACS Appl. Mater. Interfaces. 17 (9), 13552\u201313564. https:\/\/doi.org\/10.1021\/acsami.4c21289 (Mar. 2025).","DOI":"10.1021\/acsami.4c21289"},{"key":"9509_CR71","doi-asserted-by":"publisher","unstructured":"Wang, F. et al. A Spleen-Targeted tolerogenic mRNA-LNPs vaccine for the treatment of experimental asthma. Adv. Sci. (Weinh). 12, e2412543. https:\/\/doi.org\/10.1002\/advs.202412543 (Apr. 2025).","DOI":"10.1002\/advs.202412543"},{"key":"9509_CR72","doi-asserted-by":"publisher","unstructured":"Suzuki, Y. et al. Splenic B cell-targeting lipid nanoparticles for safe and effective mRNA vaccine delivery. J. Control Release. 382, 113687. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113687 (Apr. 2025).","DOI":"10.1016\/j.jconrel.2025.113687"},{"key":"9509_CR73","doi-asserted-by":"publisher","unstructured":"Yuan, L. et al. A broad-spectrum multiepitope vaccine against seasonal influenza A and B viruses in mice. eBioMedicine 106 https:\/\/doi.org\/10.1016\/j.ebiom.2024.105269 (Aug. 2024).","DOI":"10.1016\/j.ebiom.2024.105269"},{"key":"9509_CR74","doi-asserted-by":"publisher","unstructured":"Gomes, L., Monteiro, G. & Mergulh\u00e3o, F. The impact of IPTG induction on plasmid stability and heterologous protein expression by Escherichia coli biofilms. Int. J. Mol. Sci. 21 (2), 576. https:\/\/doi.org\/10.3390\/ijms21020576 (Jan. 2020).","DOI":"10.3390\/ijms21020576"},{"issue":"10","key":"9509_CR75","doi-asserted-by":"publisher","first-page":"e0258553","DOI":"10.1371\/journal.pone.0258553","volume":"16","author":"M Murakami","year":"2021","unstructured":"Murakami, M., Murakami, A. M. & Itagaki, S. A dual prokaryotic (E. coli) expression system (pdMAX). PLoS One. 16 (10), e0258553. https:\/\/doi.org\/10.1371\/journal.pone.0258553 (2021).","journal-title":"PLoS One"},{"key":"9509_CR76","doi-asserted-by":"publisher","unstructured":"Heiser, B. J., Veyssi, A. & Ghosh, D. Recent strategies for enhanced delivery of mRNA to the lungs. Nanomed. (Lond). 1\u201327. https:\/\/doi.org\/10.1080\/17435889.2025.2485669 (Apr. 2025).","DOI":"10.1080\/17435889.2025.2485669"},{"key":"9509_CR77","doi-asserted-by":"publisher","unstructured":"Azeem, M. et al. Efficacy and limitations of SARS-CoV-2 vaccines - A systematic review. Life Sci. 371, 123610. https:\/\/doi.org\/10.1016\/j.lfs.2025.123610 (Jun. 2025).","DOI":"10.1016\/j.lfs.2025.123610"},{"key":"9509_CR78","doi-asserted-by":"publisher","unstructured":"Wu, K. et al. Dec., Characterization of mRNA-LNP structural features and mechanisms for enhanced mRNA vaccine immunogenicity, J Control Release, vol. 376, pp. 1288\u20131299, (2024). https:\/\/doi.org\/10.1016\/j.jconrel.2024.11.007","DOI":"10.1016\/j.jconrel.2024.11.007"},{"key":"9509_CR79","doi-asserted-by":"publisher","unstructured":"Leong, K. Y., Tham, S. K. & Poh, C. L. Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications. Virol. J. 22 (1), 71. https:\/\/doi.org\/10.1186\/s12985-025-02645-6 (Mar. 2025).","DOI":"10.1186\/s12985-025-02645-6"},{"key":"9509_CR80","doi-asserted-by":"publisher","unstructured":"Jeon, J. & Kim, E. Exploring future pandemic preparedness through the development of preventive vaccine platforms and the key roles of international organizations in a global health crisis. Vaccines (Basel). 13 (1), 56. https:\/\/doi.org\/10.3390\/vaccines13010056 (Jan. 2025).","DOI":"10.3390\/vaccines13010056"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09509-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09509-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09509-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T06:39:04Z","timestamp":1755758344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09509-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9509"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09509-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"30698"}}